MCCG Approved as Oncology Research Site

MCCG Approved as Oncology Research Site

Hospital joins National Comprehensive Cancer Network^®

 MACON, GA (Monday, July 16, 2012) – The Medical Center of Central Georgia (MCCG) is pleased to announce that it has been approved as a National Comprehensive Cancer Network^® (NCCN^®) Oncology Research Program Affiliate and a community cancer research site.

As a qualified research site, MCCG will have opportunities to participate in multi-institutional studies conducted by NCCN^® member institutions in an effort to improve patient outcomes and advance medical science. NCCN^® affiliates execute quality clinical research through collaborations with other member institutions. The program is anticipated to not only expedite accrual milestones, but also give community researchers access to innovative therapies.

“Our selection as an NCCN Oncology Research Program Affiliate is an important step to bring cutting edge clinical research to the central Georgia community. Today, cancer patients often choose to receive their first treatment through a clinical trial. These patients may be helped by that treatment before it is widely available; and they are contributing to the overall progress in the fight against cancer,” said Nancy White, RN, Director of Oncology Services.

In the past 12 years, more than $36 million in grants have supported cancer research at 21 NCCN^® member institutions. MCCG is one of six community affiliates chosen to participate in the Affiliate Research Program initiative, thus broadening the Oncology Research Program's innovative treatment options for cancer patients in their local communities. MCCG is pleased to participate in this program's research projects in order to bring meaningful new treatments to the medical oncology community and cancer patients.